Skip to main content
  1. Regulatory, Safety & Market Access
    • Regulatory, Safety & Market Access
  2. Peptide CMC & Process Development
    • Peptide CMC & Process Development
  3. Regulatory, Safety & Market Access
    • Regulatory, Safety & Market Access
  4. Regulatory, Safety & Market Access
    • Regulatory, Safety & Market Access
  5. Innovation in Therapeutic Modalities
    •  Innovation in Therapeutic Modalities
  6. Translational & Clinical Strategy
    • Translational & Clinical Strategy
  7. Innovation in Therapeutic Modalities
    •  Innovation in Therapeutic Modalities
  8. Peptide CMC & Process Development
    • Peptide CMC & Process Development

    YMC America

  9. Peptide CMC & Process Development
    • Peptide CMC & Process Development
  10. Translational & Clinical Strategy
    • Translational & Clinical Strategy
  11. Oligonucleotide CMC & Process Development
    • Oligonucleotide CMC & Process Development
  12. Regulatory, Safety & Market Access
    • Regulatory, Safety & Market Access
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    Afternoon Refreshments
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    Evening Drinks Reception
  13. Oligonucleotide CMC & Process Development
    • Oligonucleotide CMC & Process Development
  14. Innovation in Therapeutic Modalities
    •  Innovation in Therapeutic Modalities
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    Opening Address & Keynote Presentation:
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    1-2-1 Meetings/Networking Break
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    1-2-1 Meetings/Networking Break
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    Networking Lunch
  15. Translational & Clinical Strategy
    • Translational & Clinical Strategy
  16. Oligonucleotide CMC & Process Development
    • Oligonucleotide CMC & Process Development

    ChemGenes

    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    Morning Refreshments
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    1-2-1 Meetings/Networking Break
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    1-2-1 Meetings/Networking Break
  17. Peptide CMC & Process Development
    • Peptide CMC & Process Development
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Peptide CMC & Process Development
    • Regulatory, Safety & Market Access
    Registration
  18. Translational & Clinical Strategy
    • Translational & Clinical Strategy
  19. Innovation in Therapeutic Modalities
    •  Innovation in Therapeutic Modalities
    Circular DNA exists as an endogenous molecule in human cells with emerging relevance to health and d ...
  20. Oligonucleotide CMC & Process Development
    • Oligonucleotide CMC & Process Development
    Manufacturing of long RNA oligos: Synthesis and analytical strategies and challenges  Scaling Up Oli ...